title: Infliximab: a novel treatment option for refractory orofacial granulomatosis.
authors.forename: Wiebke K
authors.initials: WK
authors.lastname: Peitsch
authors.forename: Nicole
authors.initials: N
authors.lastname: Kemmler
authors.forename: Sergij
authors.initials: S
authors.lastname: Goerdt
authors.forename: Matthias
authors.initials: M
authors.lastname: Goebeler
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D051261:Granulomatosis, Orofacial / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab